Free Trial
→ The SpaceX supplier that shipped 5 billion chips to Starlink (From Weiss Ratings) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? MarketBeat compares G Medical Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with G Medical Innovations include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to T2 Biosystems?

G Medical Innovations (NASDAQ:GMVDF) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

G Medical Innovations has a beta of 30.95, suggesting that its stock price is 2,995% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 8.21, suggesting that its stock price is 721% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

In the previous week, T2 Biosystems had 2 more articles in the media than G Medical Innovations. MarketBeat recorded 2 mentions for T2 Biosystems and 0 mentions for G Medical Innovations. G Medical Innovations' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
T2 Biosystems Neutral

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to SmileDirectClub?

SmileDirectClub (NASDAQ:SDCCQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
G Medical Innovations Neutral

SmileDirectClub has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 30.95, indicating that its share price is 2,995% more volatile than the broader market.

G Medical Innovations has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
G Medical Innovations N/A N/A N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

G Medical Innovations (NASDAQ:GMVDF) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
ViewRay Neutral

G Medical Innovations has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
ViewRay$102.21M0.00-$107.33M-$0.31N/A

G Medical Innovations has a beta of 30.95, meaning that its share price is 2,995% more volatile than the broader market. Comparatively, ViewRay has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
ViewRay N/A N/A N/A

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 2.5% of ViewRay shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

G Medical Innovations (NASDAQ:GMVDF) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

G Medical Innovations has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Acutus Medical Neutral

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

G Medical Innovations has a beta of 30.95, suggesting that its stock price is 2,995% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 6.08, suggesting that its stock price is 508% more volatile than the broader market.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
G Medical Innovations Neutral

Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 30.95, suggesting that its stock price is 2,995% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
G Medical Innovations N/A N/A N/A

6.0% of G Medical Innovations shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

G Medical Innovations has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$26K$53.33M$6.46B$12.34B
Dividend YieldN/A1.08%2.76%5.28%
P/E RatioN/A18.6821.2125.65
Price / SalesN/A37.51554.3886.31
Price / CashN/A18.8743.4956.67
Price / BookN/A16.1510.377.14
Net Income-$24.63M-$20.25M$3.57B$335.98M

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-99.9%$63K$7.68MN/A180
SDCCQ
SmileDirectClub
N/A$0.00
-90.0%		N/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
AFIB
Acutus Medical
N/A$0.00
-50.0%		N/A-99.0%$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Trump Admin to Pump $1 Billion into this “Off-the-Radar” AI Stock
The U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...
InvestorPlace | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Gold surged 600 dollars last time this indicator peaked
The Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...
Porter & Company | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel